CD14 gene -260 C/T polymorphism is associated with chronic heart failure

Area of Science:

• Genetics
• Cardiology
• Immunology

Background:

• Chronic heart failure (CHF) is linked to inflammation and elevated TNFalpha and endotoxin levels.
• The specific role of the CD14 C(-260)T polymorphism in CHF development remains unclear.
• Investigating genetic factors like CD14 polymorphisms can offer new insights into CHF pathogenesis.

Purpose of the Study:

• To determine if the CD14 C(-260)T promoter polymorphism is associated with an increased risk of developing CHF.
• To explore the genetic susceptibility to CHF based on CD14 gene variations.
• To analyze the frequency of CD14 genotypes in CHF patients and healthy controls.

Main Methods:

• A case-control study involving 100 CHF patients and 100 healthy controls.
• Genotyping of the CD14 C(-260)T polymorphism was conducted using the PCR-RFLP technique.
• Demographic and clinical data, including left ventricular ejection fraction (LVEF), were collected and compared.

Main Results:

• The T allele frequency was significantly lower in CHF patients (38%) compared to controls (48%).
• Conversely, the C allele frequency was higher in CHF patients (62%) than in controls (52%).
• The TT genotype was significantly underrepresented in CHF patients (14%) compared to controls (28%).

Conclusions:

• The CD14 C(-260)T polymorphism appears to influence susceptibility to CHF.
• A lower frequency of the T allele and underrepresentation of the TT genotype in CHF patients suggest a protective role.
• The TT genotype may represent a novel genetic protective factor against the development of chronic heart failure.